LSD-Assisted Therapy for Anxiety Associated with Life-Threatening Illness

Location: Solothurn, Switzerland

MAPS is proud to sponsor the first study of the therapeutic use of LSD in humans in over 35 years. This study, based in Switzerland, investigates the safety and effectiveness of LSD-assisted psychotherapy in subjects with life-threatening illnesses and who are experiencing associated anxiety. The study received final approval from the BAG (the Swiss DEA) on December 5, 2007, final approval from the Ethics Committee (the Swiss IRB equivalent) on October 30, 2007, and clearance from SwissMedic (the Swiss FDA equivalent) on November 8, 2007. The first subject was enrolled on April 23, 2008, and all subjects have now been treated.

This study has cost $190,000; all of which has been raised.

Generous donations have been made by Robert Barnhart ($125,000), Kevin Herbert ($18,750), Vanja Palmers ($10,000), Fredi Muller (10,000 SF), Amanda Feilding/Beckley Foundation (5000 Euros), and Anonymous ($5,000). Thank you to all who contributed through book and art purchases as well!